A nitrofuran antibiotic used exclusively for the treatment and prophylaxis of uncomplicated urinary tract infections. Active against most common UTI pathogens including E. coli (resistance remains low), Enterococcus faecalis, S. saprophyticus, and Klebsiella. Does not achieve therapeutic serum or tissue concentrations, so it is only effective for lower urinary tract (bladder) infections.
Nausea (most common, reduced with macrocrystal form)
Headache
Flatulence
Severe renal impairment (CrCl <30 mL/min), inadequate urinary drug concentration and increased toxicity risk
Pregnancy at term (38-42 weeks), risk of hemolytic anemia in neonate
The bottom line
Evidence rating strong. Most-documented uses: first-line treatment for uncomplicated lower uti (cystitis), uti prophylaxis (recurrent infections), low resistance rates (multi-target mechanism). 10 sources indexed (2015–2025), with 2 interaction records on file.
The science
How it works, mechanistically.
Core mechanism
A prodrug that is reduced by bacterial nitroreductases to form highly reactive electrophilic intermediates. These intermediates attack bacterial ribosomal proteins, DNA, and other macromolecules through multiple mechanisms simultaneously, inhibiting protein synthesis, aerobic energy metabolism, DNA synthesis, RNA synthesis, and cell wall synthesis. This multi-target mechanism results in a very low rate of resistance development.
Class
Nitrofuran Antibiotic
Absorption
Water-soluble; take with food
Dosing
Dosing & protocol.
Common range
Macrobid: 100 mg every 12 hours x 5 days; Macrodantin: 50-100 mg QID x 7 days; prophylaxis: 50-100 mg at bedtime (as prescribed by your physician)
Recommended form
Oral capsules (Macrobid macrocrystals/monohydrate preferred) or suspension
Take with food to increase absorption and reduce GI upset. Food increases bioavailability by approximately 40%. The macrocrystal form (Macrobid) has slower dissolution, providing more sustained urinary levels and fewer GI side effects.10
Safety
Full safety detail.
Side effects
Nausea (most common, reduced with macrocrystal form)
Headache
Flatulence
Brown-orange urine discoloration (harmless)
Pulmonary toxicity (acute hypersensitivity or chronic fibrosis with prolonged use)
Peripheral neuropathy (with prolonged use or renal impairment)
Hepatotoxicity (rare)
Contraindications
Severe renal impairment (CrCl <30 mL/min), inadequate urinary drug concentration and increased toxicity risk
Pregnancy at term (38-42 weeks), risk of hemolytic anemia in neonate
Magnesium-containing antacids and supplements have been shown to reduce nitrofurantoin absorption, an effect first demonstrated for magnesium trisilicate and extended to other magnesium salts. The reduction can lower urinary nitrofurantoin concentrations below the threshold needed to treat urinary tract infections.
Recommendation: Take nitrofurantoin at least 2 hours before or 2 hours after magnesium glycinate. Do not co-administer.
Probiotic supplementation during nitrofurantoin therapy reduces antibiotic-associated diarrhea and helps preserve gut microbiome diversity. Probiotics may also reduce recurrence rates of urinary tract infections in some studies.
Recommendation: Take probiotics throughout your nitrofurantoin course, separated by at least 2 hours from each antibiotic dose. Continue for at least 1 week after the antibiotic ends.
Huttner A, Verhaegh EM, Harbarth S et al.. Nitrofurantoin revisited: a systematic review and meta-analysis of controlled trials. The Journal of antimicrobial chemotherapy. 2015
Perry C, Hossain M, Powell M et al.. Design of Two Phase III, Randomized, Multicenter Studies Comparing Gepotidacin with Nitrofurantoin for the Treatment of Uncomplicated Urinary Tract Infection in Female Participants. Infectious diseases and therapy. 2022
Wagenlehner F, Perry CR, Hooton TM et al.. Plain language summary: efficacy and safety of gepotidacin, a new oral antibiotic, compared with nitrofurantoin, a commonly used oral antibiotic, for treating uncomplicated urinary tract infection. Future microbiology. 2025
Recht J, Chansamouth V, White NJ et al.. Nitrofurantoin and glucose-6-phosphate dehydrogenase deficiency: a safety review. JAC-antimicrobial resistance. 2022
This page is educational. Do not start, stop, or change a supplement or medication based on it without checking with a qualified healthcare professional.
Use this with your stack
Nitrofurantoin in NutriStack.
Add it to your stack, see how it interacts with everything else you take, and get a Stack Score that updates the moment it does.
NutriStack is an informational and organizational tool, not a medical service, and not a substitute for professional advice. Always consult a qualified healthcare professional before starting, stopping, or changing any supplement or medication.